New study tracks smoldering myeloma to predict dangerous progression
NCT ID NCT06212323
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people with high-risk smoldering myeloma, a condition that may turn into active cancer. Researchers use advanced MRI scans and regular check-ups to track how the disease changes over two years. The goal is to better understand who progresses and how to improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOLDERING MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huntsman Cancer Institute at the University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new immunotherapy stop smoldering myeloma before it becomes active cancer?
- New blood test screening targets hidden cancer in black communities
- New antibody shows promise in slowing early myeloma
- 1,000 volunteers help scientists unlock the mystery of myeloma progression
- Can a cancer drug stop myeloma before it starts?
- New italian network aims to catch rare blood disease earlier